Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare primary bone dysplasia disorder characterized by congenital hypotrichosis associated with rhizomelic short stature (more pronounced in upper limbs than lower limbs), limited hip abduction and mild genu varum. Flared and irregular metaphyses, delayed and irregular epiphiseal ossification and pear-shaped vertebral bodies are characteristic radiologic findings.
Biomarker and diagnostic research for spondyloepimetaphyseal dysplasia-hypotrichosis syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spondyloepimetaphyseal dysplasia-hypotrichosis syndrome.
25 publications have been identified in PubMed for spondyloepimetaphyseal dysplasia-hypotrichosis syndrome. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (25%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 33% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 9:30 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
6 |
25% |
Laboratory research | 4 | 17% |
Testing and diagnosis research | 2 | 8% |
Research summaries | 2 | 8% |
Other research | 1 | 4% |
Clinical study results | 1 | 4% |
Belton S (2026). [PMID: 42076812](https://pubmed.ncbi.nlm.nih.gov/42076812/). *Health Expect*. [Clinical Trial Publication]
Chand K (2026). [PMID: 42068746](https://pubmed.ncbi.nlm.nih.gov/42068746/). *Biochem Biophys Res Commun*. [Basic Science / Preclinical]
Guhlin J (2026). [PMID: 42120682](https://pubmed.ncbi.nlm.nih.gov/42120682/). *Nat Ecol Evol*. [Epidemiology / Natural History]
Corbin M (2026). [PMID: 41550612](https://pubmed.ncbi.nlm.nih.gov/41550612/). *Lancet Reg Health West Pac*. [Epidemiology / Natural History]
Gray S (2026). [PMID: 41297111](https://pubmed.ncbi.nlm.nih.gov/41297111/). *J Emerg Med*. [Diagnostic / Biomarker]
Halis M (2026). [PMID: 41549465](https://pubmed.ncbi.nlm.nih.gov/41549465/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Reed RM (2025). [PMID: 38230432](https://pubmed.ncbi.nlm.nih.gov/38230432/). *Proc Nutr Soc*. [Review / Meta-Analysis]
Zamanian Najafabadi S (2025). [PMID: 40751525](https://pubmed.ncbi.nlm.nih.gov/40751525/). *Arch Iran Med*. [Case Report / Case Series]
Sanchez-Garcia MA (2025). [PMID: 41152617](https://pubmed.ncbi.nlm.nih.gov/41152617/). *Nat Immunol*. [Basic Science / Preclinical]
Murtaugh B (2025). [PMID: 39433705](https://pubmed.ncbi.nlm.nih.gov/39433705/). *Neurocrit Care*. [Other]